# Spruce Biosciences, Inc.: Form DEF 14A, filed Apr 7, 2022

- Company: [Spruce Biosciences, Inc.](/companies/sprb.md) (CIK 1683553)
- Form: DEF 14A
- Filed: 2022-04-07
- Accepted by EDGAR: Apr 7, 2022, 16:49 ET
- Period: 2022-05-25
- Accession: 0001140361-22-013615
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1683553/000114036122013615/ny20002517x1_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1683553/000114036122013615/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1683553/000114036122013615/ny20002517x1_def14a.htm

Filed Apr 7, 2022.
Source: SEC EDGAR, the filing index for accession 0001140361-22-013615. Last ingested by Listed: Nov 9, 2026, 17:52 ET. No prices; not investment advice.
